Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia
Thitipon Yaowaluk1, Vorapun Senanarong2, Chanin Limwongse3, Rasda Boonprasert4, Pornpimol Kijsanayotin1 1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; 2Division of Neurology, Department of Medicine, Faculty of Medicine, Si...
Saved in:
Main Authors: | Yaowaluk T (Author), Senanarong V (Author), Limwongse C (Author), Boonprasert R (Author), Kijsanayotin P (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stereoselective metabolism of donepezil and steady-state plasma concentrations of S-donepezil based on CYP2D6 polymorphisms in the therapeutic responses of Han Chinese patients with Alzheimer's disease
by: Jin Lu, et al.
Published: (2015) -
CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia
by: Chamnanphon M, et al.
Published: (2020) -
Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
by: Sychev DA, et al.
Published: (2017) -
Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
by: Ortner M, et al.
Published: (2020) -
Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome
by: Min Li, et al.
Published: (2018)